INS and type 1 diabetes mellitus: Despite an early 1983 study indicating plasmapheresis improved C-peptide levels over 18 months—leading to longer partial disease remission, reductions in autoantibody detection, and no increases in insulin requirements—little research has been performed on therapeutic apheresis and Type 1 diabetes (T1D).